FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/04/2025
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Case type
Recorded events
Latest update
Classification
Trademark type
Nice classes
Filing date
Registration date
Expiration date
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Structured fields from the responsible authority and the official record.
Status date
Last transaction
Responsible office
Status code
Official register
Drawing code
Owner type
Owner location
Examiner
Current location
Holders
Representatives
Joesph A. R. Gerber Knobbe, Martens, Olson & Bear, LLP
Nice Classes
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Dietary supplements; nucleic acid sequences for medical purposes; cultures of microorganisms for medical use; biotechnological preparations for medical use, namely, cells, recombinant DNA sequences, synthetic RNA sequences, and oligonucleotides for use in treating and repairing damaged human tissue through tissue nanotransfection (TNT); reagent paper for medical purposes; drugs for medical purposes, namely, cardiovascular pharmaceuticals, anti-diabetic pharmaceuticals, metabolic pharmaceuticals, antibacterial pharmaceuticals, macular degeneration treatment pharmaceuticals (or ophthalmic pharmaceuticals), hair loss treatment pharmaceuticals, hepatitis treatment pharmaceuticals, respiratory disease treatment pharmaceuticals, neurological disease treatment pharmaceuticals, hepatological disease treatment pharmaceuticals; synthetic peptides for the treatment of metabolic, ophthalmic, cardiovascular, pulmonary, hepatological, respiratory, neurological diseases and disorders; cardiovascular pharmaceuticals, anti-diabetic pharmaceuticals, antibacterial pharmaceuticals, macular degeneration treatment pharmaceuticals (or ophthalmic pharmaceuticals), hair loss treatment pharmaceuticals, hepatitis treatment pharmaceuticals, respiratory disease treatment pharmaceuticals, neurological disease treatment pharmaceuticals, hepatological disease treatment pharmaceuticals; materials for dental fillings; colostral antibodies for medical purposes, monoclonal antibodies for medical purposes, hybrid antibodies for medical purposes; all the foregoing for human use and excluding goods related to the care and feeding of animals and plants
Class 42
Product research and development in the field of biotech technology; scientific research in the field of biotechnology, medical research in the field of biotechnology; scientific research and scientific investigations for medical purposes in the field of biomedicine; scientific research consultation and providing scientific research information both of the foregoing in the field of biomedicine; bacteriological research; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; pharmaceutical research services; scientific research in the field of genetics; medical research laboratory services; Scientific research and scientific investigations for medical purposes, both of the foregoing in the fields of medicine, health and pharmacology; medical research; All the above-mentioned services excluding services related to the care and feeding of animals and plants
History of USPTO decisions and trademark events.
45 publications found
FINAL DECISION TRANSACTION PROCESSED BY IB
01/04/2025
FINAL DISPOSITION NOTICE SENT TO IB
12/13/2024
FINAL DISPOSITION PROCESSED
12/13/2024
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/09/2024
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/09/2024
REGISTERED-PRINCIPAL REGISTER
07/09/2024
NOTIFICATION PROCESSED BY IB
04/29/2024
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/23/2024
PUBLISHED FOR OPPOSITION
04/23/2024
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/10/2024
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/10/2024
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/03/2024
APPROVED FOR PUB - PRINCIPAL REGISTER
03/12/2024
TEAS/EMAIL CORRESPONDENCE ENTERED
02/07/2024
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/06/2024
TEAS REQUEST FOR RECONSIDERATION RECEIVED
02/06/2024
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/13/2024
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
01/08/2024
CONTINUATION OF FINAL REFUSAL E-MAILED
01/08/2024
ACTION CONTINUING A FINAL - COMPLETED
01/08/2024
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/27/2023
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/27/2023
TEAS/EMAIL CORRESPONDENCE ENTERED
11/22/2023
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/21/2023
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/21/2023
NOTIFICATION OF FINAL REFUSAL EMAILED
05/24/2023
FINAL REFUSAL E-MAILED
05/24/2023
FINAL REFUSAL WRITTEN
05/24/2023
TEAS/EMAIL CORRESPONDENCE ENTERED
05/03/2023
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/02/2023
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/02/2023
ATTORNEY REVIEW COMPLETED
02/01/2023
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
01/12/2023
REFUSAL PROCESSED BY IB
01/04/2023
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/12/2022
REFUSAL PROCESSED BY MPU
12/12/2022
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
10/28/2022
LIMITATION OF GOODS RECEIVED FROM IB
10/01/2022
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/29/2022
NON-FINAL ACTION WRITTEN
09/28/2022
ASSIGNED TO EXAMINER
09/28/2022
CORRECTION TRANSACTION RECEIVED FROM IB
07/23/2022
APPLICATION FILING RECEIPT MAILED
03/15/2022
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/10/2022
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/03/2022
Continuous trademark protection
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.